Ocular Therapeutix™ To Present New Data at the American Society of Cataract and Refractive Surgery (ASCRS) 2020 Virtual Annual Meeting
BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced multiple presentations at the American Society of Cataract and Refractive Surgery (ASCRS) 2020 Virtual Annual Meeting, May 16-17, 2020. "We are thrilled with the clinical benefits we have seen with DEXTENZA for the treatment of inflammation and pain following o